Geno
Cocoa, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
TB
Todd BradyDirector
TM
Theo Melas-KyriaziDirector
BF
Brent FurseExecutive Officer, Director
VP
Vinzenz PloererDirector
DH
David H. Fine, Ph.D.Executive Officer, Director
TS
Tod ShultzExecutive Officer
DS
Dan Salazar, Ph.D.Director
AL
Anthony LoumidisExecutive Officer
PA
Paul AntinoriExecutive Officer
TS
T. Scott Johnson, M.D.Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$27.3MraisedDec 2021 · 5 investors · PharmaceuticalsRule 506(b)
▶$27.3MraisedDec 2021 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Todd BradyDirector
- Daniel SalazarDirector
- Thiago TavaresDirector
- Shasha ZouExecutive Officer
- Eric BednarskiDirector
- Brent V. FurseExecutive Officer, Director
- Roberto CohenExecutive Officer
- Offering amount
- $99.5M
- Amount sold
- $27.3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.9MraisedSep 2017 · 31 investors · PharmaceuticalsRule 506(b)
▶$29.9MraisedSep 2017 · 31 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Todd BradyDirector
- Theo Melas-KyriaziDirector
- Brent FurseExecutive Officer, Director
- Vinzenz PloererDirector
- David H. Fine, Ph.D.Executive Officer, Director
- Tod ShultzExecutive Officer
- Dan Salazar, Ph.D.Director
- Anthony LoumidisExecutive Officer
- Paul AntinoriExecutive Officer
- T. Scott Johnson, M.D.Director
- Offering amount
- $35.1M
- Amount sold
- $29.9M
- First sale
- Sep 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.